1990
DOI: 10.1016/0091-6749(90)90104-c
|View full text |Cite
|
Sign up to set email alerts
|

Effects of oral cetirizine, a selective H antagonist, on allergen- and exercise-induced bronchoconstriction in subjects with asthma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
12
0

Year Published

1992
1992
2007
2007

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 24 publications
(12 citation statements)
references
References 35 publications
0
12
0
Order By: Relevance
“…The histamine-1 receptor antagonists (55,56) and anticholinergic drugs (57) seem to be rather ineffective in this setting. A long-term treatment with inhaled corticosteroids attenuates the response to cold air (58-61), indicating that this response is associated with the degree of asthmatic inflammation in the lower airways.…”
Section: Cold Air-provoked Short-term Responsesmentioning
confidence: 99%
“…The histamine-1 receptor antagonists (55,56) and anticholinergic drugs (57) seem to be rather ineffective in this setting. A long-term treatment with inhaled corticosteroids attenuates the response to cold air (58-61), indicating that this response is associated with the degree of asthmatic inflammation in the lower airways.…”
Section: Cold Air-provoked Short-term Responsesmentioning
confidence: 99%
“…Investigations of the effect of H 1 blockers on the EAR have produced variable and inconclusive results. [1][2][3][4][5] Leukotriene modifiers have been shown to provide reasonable inhibition of the EAR and LAR but do not completely abolish the response. [6][7][8][9][10] The idea that a mechanism involving multiple mediators might require multiple interventions continues to attract interest in the role of combination therapies for the treatment of atopic asthma.…”
mentioning
confidence: 99%
“…However, recent studies highlighted that the extent of protection diminishes with their exclusive regular use after 6-8 weeks both for short-acting and long-acting agonists (reviewed in [4]). Histamine has been implicated in EIB but antihistamines have been shown to offer modest protection against EIB [5]. However, there is some evidence that combined mediator blockade with both leukotriene and histamine-receptor antagonists results in greater symptom control than LTRAs alone in patients with persistent asthma [6].…”
mentioning
confidence: 99%